Global Clinical Next-Generation Sequencing Market Report: Learn the Emerging Clinical Applications and Best Practices to the Road to Reimbursement

Jan 06, 2016, 06:00 ET from Research and Markets

DUBLIN, January 6, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/xsxsch/global_clinical) has announced the addition of the "Global Clinical Next-Generation Sequencing Market" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
 
This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tables have been provided for select companies providing NGS-based testing for clinical use, pricing of panels, and CAP survey analysis. Profiles of direct-to-consumer testing genetic testing companies are provided in the report. 

Where? 

The market is inclined towards the use of NGS testing within prenatal testing, oncology, inherited diseases, and transplant diagnostics. China remains an attractive market with well-established guidelines to regulate the use of gene tests. Unlike other countries, China has offered support to hospital labs to deploy NGS-based testing. 

Why? 

The cost of the technology and intense labor requirements prohibit adoption of the technology in clinics. Several tests offered in the United States are primarily in the LDT landscape and do not confer the Food and Drug Administration (FDA) route and will be subjected to scrutiny under the new LDT regulation. 

How? 

Regulatory strategy, study design, and publication strategy lead to a positive coverage decision. These strategies need to be considered at early stages. Successful companies choose the technical platform that suits business, clinical, and test performance needs. 

Key Topics Covered: 

1. Executive Summary 

2. Market Overview 

3. Market Outlook 

4. Best Practices on Reimbursement Coverage 

5. Barriers to Adoption 

6. Appendix - Testing Trends by Method 

For more information visit http://www.researchandmarkets.com/research/xsxsch/global_clinical

About Research and Markets 

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact: 

Laura Wood
+353-1-481-1716
press@researchandmarkets.net


SOURCE Research and Markets